F.D.A. Names Agency Veteran to Run Drug Division www.nytimes.com/2025/11/11/s...

Artificial intelligence in hematology url: ashpublications.org/blood/articl...

Hopefully on my way to Alliance meeting in Chicago- look forward to Transplant and Cellular Based Therapies Committee tomorrow

A team at MSK is shedding new light on #VEXAS syndrome, a severe autoinflammatory condition arising from a mutation in the UBA1 gene. “We are hopeful that the therapeutic targets identified by our research can pave the way for new approaches.” says @gitlinlabmsk.bsky.social. bit.ly/4oRQ5LF

‘Intentional’ Explosion Took Place at Harvard Medical School, Officials Say www.nytimes.com/2025/11/01/u...

Great meeting with friends and colleagues to discuss chronic GVHD last week in Detroit with Steven Pavletic, Daniel Couriel, Corey Cutler, Stephanie Lee & Stefanie Sarantopoulos

MSK researchers presented exciting advances in medical oncology for a range of cancer types at the @myesmo.bsky.social Congress 2025 held in Berlin. Highlights include the latest updates on phase 1 trials testing innovative treatment approaches for select patients w/ advanced solid tumors and more:

At #ESMO25, Rebecca Dent will present the results of a phase 3 study of first-line datopotamab deruxtecan for those w/ inoperable or metastatic triple-negative #breastcancer. @mskcancercenter.bsky.social's Tiffany Traina is the senior author. 🗓️ October 19, 9:25 a.m. CEST Learn more: bit.ly/4n5B8od

Our comprehensive Review on MGUS: Monoclonal Gammopathy of Undetermined Significance @NEJM 5% of people over age 50 have MGUS. Every physician needs to know and understand MGUS. Lots of Tables and Figures. www.nejm.org/doi/abs/10.1...

Happening next at #ESMO25: Yelena Janjigian will lead a session on how she and other experts are identifying new treatments to improve outcomes for those with gastroesophageal adenocarcinoma. @mskcancercenter.bsky.social @myesmo.bsky.social Learn more: bit.ly/3WcyfH5

Tomorrow at #ESMO25, Dr. Vicky Makker will present at an education session about selecting the best first-line treatment based on molecular classification. @mskcancercenter.bsky.social @myesmo.bsky.social Learn more: bit.ly/3W6rqqz

Very honored to give Ciril Rozmán Lecture at the annual meeting of the Spanish Society of Hematology and Hemotherapy @sehhematologia.bsky.social. The Ciril Rozmán Award recognizes a foreign hematologist who has made high-level scientific contributions and has had close ties with Spanish experts.

Since 2012, the ASH Bridge Grant has funded 205 researchers with $28M, leading to $680M in follow-on NIH funding. These grants keep labs running and fuel breakthroughs in hematology. Learn more: https://bit.ly/48yINrB

At 7 years old, Emily became the first child in the world to receive CAR T-cell therapy. After three relapses and being sent to hospice, Emily got a second chance at life with this treatment. Help protect access to life-saving treatments: https://ow.ly/rXY150X5Tso #Fight4Hematology #HemeSky

Very honored to give Ciril Rozmán Lecture at the annual meeting of the Spanish Society of Hematology and Hemotherapy @sehhematologia.bsky.social. The Ciril Rozmán Award recognizes a foreign hematologist who has made high-level scientific contributions and has had close ties with Spanish experts.

@drmiguelperales.bsky.social at #Hemato2025 VII Conferencia Ciril Rozman

Un merecido reconocimiento al @drmiguelperales.bsky.social por su larga trayectoria. Siempre dispuesto a compartir conocimientos y procurar que los residentes de España puedan visitar @mskcancercenter.bsky.social. Para mi una de las mejores experiencias de mi residencia. 👏Muchas felicidades👏

🎙️New Podcast Episode! Join host HemaSphere Scientific Editor Dr Charles de Bock as he chats with Dr Kai Rejeski. The conversation delves into the complexities of CAR-T therapy, particularly focusing on the associated toxicities & the need for a structured grading system. 👉https://bit.ly/46xKjZA

Great session on cGVHD at #COSTEM2025 in Berlin last week. Got to debate Dr. Francesca Kinsella

Go see Art on Broadway. Great show!

Brandenburg Gate #berlin

BMT InfoNet invites your patients to a free live webinar with leading CAR T-cell therapy experts. Encourage your patients and caregivers to register and submit their questions in advance! 🗓 Tuesday, October 21 🕖 7:00 PM ET 🔗 bmtinfonet.org/event/ask-ca...

💉New study of HPV vaccine shows “robust population-level effectiveness & herd protection in adolescent girls & young women” From 2006-2023: ➡️ Proportion of vaxxed women positive for high-risk HPV-16 & -18 types fell 98.4%, proportion of unvaxxed women fell 71.6% 1/2 jamanetwork.com/journals/jam...

In a patient with treatment-resistant ulcerative colitis, CD19 CAR T-cell therapy led to drug-free remission and mucosal healing, suggesting that B-cell targeting may offer a novel therapeutic pathway. Read the full report: nej.md/48gcBZV #MedSky #GastroSky

@bloomberg.com reports that a top advisor to RFK Jr. said they're considering adding autism symptoms to the federal vaccine court program. Read my story for @nbcnews.com on how that could bring a halt to vaccine manufacturing in the U.S. www.nbcnews.com/health/healt...

Medical Groups Warn Against Visa Fees for Foreign Doctors www.nytimes.com/2025/09/26/h...

This is huge: “A drug that provides near-perfect protection against H.I.V. with shots just twice a year will be made available at $40 per patient annually in low- and middle-income countries, offering new hope… making lenacapavir a realistic choice in countries with constrained resources.”

Kennedy says he wants to restore trust in vaccines. His hand-picked ACIP panel raised many doubts, and outside experts were left baffled and frustrated. www.statnews.com/2025/09/19/w...

Today is World Marrow Donor Day! We hope you will join us today in thanking the selfless individuals who register and donate stem cells to save the lives of patients in need. #WMDD25 #PedsHemeOnc #PHODocs #hematology

MSK pediatric hematologist-oncologist Dr. Neerav Shukla, who led the research, shares that the testing provides real-time diagnostic, prognostic, and therapeutic information to local physicians and their patients. Learn more ⬇️

Coming up at #IMS25: Dr. Sham Mailankody will share the results of a phase 1 clinical trial of concurrent BCMA and GPRC5D #CARTcells for relapsed/refractory #multiplemyeloma. 🗓️ Thursday, September 18 | 4:40 p.m. EDT @mskcancercenter.bsky.social @szusmani.bsky.social @myeloma-society.bsky.social

At #IMS25, Dr. Francesco Maura will present new research on the genomics that define neoplastic transformation in #multiplemyeloma precursor conditions. #mmsm 🗓️ Saturday, September 20 | 9:20 a.m. EDT @mskcancercenter.bsky.social @myeloma-society.bsky.social @szusmani.bsky.social

Which one is it going to be? www.economist.com/leaders/2025... www.nytimes.com/2025/09/14/m...

The announcement of health insurance companies that they’ll continue covering routine vaccinations is a huge vote of no confidence in ACIP's recommendations. It reflects a desire by insurers to avoid the cost of illnesses by having their customers vaccinated. Gift link:

Coming up at #IMS25: Join MSK's Myeloma Service Chief @szusmani.bsky.social to learn about current challenges in #multiplemyeloma relapse & future research needed to overcome them. #mmsm 🗓️ Friday, September 19 | 9:40 a.m. EDT @mskcancercenter.bsky.social @myeloma-society.bsky.social

There are 18 million cancer survivors in the U.S. That’s 6x more than there were 50 years ago, thanks to decades of progress driven in large part by federally funded research. We can’t go back. Take action with us: brnw.ch/21wVV2D #SaveResearchStopCancer #ASCOAdvocacy

We're thrilled to be here on BlueSky to bring you the latest practice-changing oncology research from all six JCO Journals! Follow-us for great content from #JCO, #JCOOP, #JCOGO, #JCOPO, #JCOCCI, & #JCOOA.

🎉 Congrats to MSK's most recent Awards & Appointments honorees, including Dr. Matthew Bott joining the @lcrf.org Scientific Advisory Board and Dr. Martin Weiser, Dr. Julio Garcia-Aguilar, and Dr. Emmanouil Pappou for being named 2025 America’s Leading Doctors in Colorectal Surgery by @newsweek.com.

MSK’s Gerstner Sloan Kettering Graduate School of Biomedical Sciences is now accepting applications for its Cancer Biology and Cancer Engineering #PhD programs for the 2026 academic year. Apply below:

David Baltimore, Nobel-Winning Molecular Biologist, Dies at 87 www.nytimes.com/2025/09/07/s...

Some thoughts about vaccines stimulated by a robust RCT using real world data and efficient methods. jamanetwork.com/journals/jam...

With @nmdp Mexico team at Mexican Transplant meeting in Merida

Honoured to have contributed a @bloodjournals.hematology.org Commentary (doi.org/10.1182/bloo...) on a recent study by @drmiguelperales.bsky.social @mskcancercenter.bsky.social highlighting improved outcomes with alloSCT in r/r cHL after prior ICI exposure (doi.org/10.1182/bloo...)

After a partially matched transplant, #GVHD can result. Previously, partially matched donors caused more GVHD than fully matched donors in cancer patients. A new approach, using cyclophosphamide, can prevent most GVHD. Read more: cibmtr.org/Files/Patien...

Just Published in Transplantation and Cellular Therapy Journal: Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR. Read more: www.sciencedirect.com/science/arti...

Great to see call to action by @nmdp-org.bsky.social at our local bus stop in NYC. Register to be a stem cell transplant donor and save a life! #bmtsm #bloodcancers

US childhood vaccination rates continue to fall, CDC data show The national percentage of kindergartners with an exemption from one or more vaccine rose to 3.6%, hitting a new high for the fourth year in a row. www.cidrap.umn.edu/c...

🎉 Congratulations to MSK's most recent Awards & Appointments honorees, including MSK being ranked the Best Cancer Center in the Northeast and First in the Nation for Urology Care by @usnews.com, and more: www.mskcc.org/news-release...

A US Senate committee endorsed maintaining the NIH's structure and increasing its funding by US$400 million, or about 1% go.nature.com/4mg193S